[
Ga-DOTA.SA.FAPi PET/CT; [177Lu
Glioblastoma multiforme; [68 Ga
Lu-DOTAGA.Glu.(FAPi)2 therapy
Journal
Nuclear medicine and molecular imaging
ISSN: 1869-3474
Titre abrégé: Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101530478
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
received:
07
04
2023
revised:
13
06
2023
accepted:
03
07
2023
pmc-release:
01
02
2025
medline:
23
1
2024
pubmed:
23
1
2024
entrez:
23
1
2024
Statut:
ppublish
Résumé
In this case report, we present the clinical management of a 52-year-old female patient with a recurrent right temporo-parietal glioblastoma multiforme (GBM). The patient presented with symptoms of headache and loss of balance and recurrence on magnetic resonance imaging (MRI). To evaluate the fibroblast activation protein inhibitor (FAPi) expression in the recurrent lesion, an exploratory [
Identifiants
pubmed: 38261876
doi: 10.1007/s13139-023-00814-5
pii: 814
pmc: PMC10796854
doi:
Types de publication
Case Reports
Langues
eng
Pagination
32-34Informations de copyright
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Déclaration de conflit d'intérêts
Competing InterestsSanjana Ballal, Madhav P. Yadav, Shobhana Raju, Frank Roesch, Marcel Martin, Madhavi Tripathi, and Chandrasekhar Bal have no relevant financial or non-financial interests to disclose.